Concepedia

Güllü Görgün

GG

Statistics

Publications

43

Citations

5.1K

H-Index

33

Active since

2001

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Massachusetts General Hospital

Tufts Medical Center

VA Boston Healthcare System

Güllü Görgün is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

2001–2022

43

Publications

43

Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug

Alan G. Ramsay, Amy J. Johnson, Abigail M. Lee et al. · Journal of Clinical Investigation · 2008 · 587 citations · Full text

, , +12

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

Naoya Mimura, Mariateresa Fulciniti, Güllü Görgün et al. · Blood · 2012 · 431 citations · Full text

Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans

Güllü Görgün, Gregory Whitehill, Jennifer L. Anderson et al. · Blood · 2013 · 382 citations · Full text

Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma

Güllü Görgün, Mehmet Samur, Kristen Cowens et al. · Clinical Cancer Research · 2015 · 299 citations · Full text

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells

Güllü Görgün, Tobias A.W. Holderried, David Zahrieh et al. · Journal of Clinical Investigation · 2005 · 297 citations · Full text

, , +16

1–5 of 43